NantKwest, Inc. Note Agreements
21 Contracts & Agreements
- Amended and Restated Promissory Note between ImmunityBio, Inc. and Nant Capital, LLC dated December 29, 2023 (Filed With SEC on March 19, 2024)
- Letter Amendment dated December 29, 2023 to the Convertible Promissory Notes dated March 31, 2023 (as amended on September 11, 2023) and September 30, 2023 issued by ImmunityBio,... (Filed With SEC on March 19, 2024)
- Convertible Promissory Note dated (Filed With SEC on November 9, 2023)
- Promissory Note between ImmunityBio, Inc. and Nant Capital, LLC dated June 1 (Filed With SEC on June 14, 2023)
- Convertible Promissory Note by and between the Company and Nant Capital, LLC dated as of March 31, 2023 (Filed With SEC on March 31, 2023)
- Promissory Note between the Company and Nant Capital, LLC dated December 12, 2022 (Filed With SEC on December 12, 2022)
- Second Amended and Restated Convertible Promissory Note between ImmunityBio, Inc. and NantMobile, LLC dated August 31, 2022 (Filed With SEC on November 9, 2022)
- Second Amended and Restated Convertible Promissory Note between ImmunityBio, Inc. and NantCancerStemCell, LLC dated August 31, 2022 (Filed With SEC on November 9, 2022)
- Second Amended and Restated Convertible Promissory Note between ImmunityBio, Inc. and NantWorks, LLC dated August 31, 2022 (Filed With SEC on November 9, 2022)
- Second Amended and Restated Convertible Promissory Note between ImmunityBio, Inc. and Nant Capital, LLC dated August 31, 2022 (Filed With SEC on November 9, 2022)
- Amended and Restated Convertible Promissory Note between ImmunityBio, Inc. and Nant Capital, LLC dated August 31, 2022 (Filed With SEC on November 9, 2022)
- Amended and Restated Convertible Promissory Note between ImmunityBio, Inc. and Nant Capital, LLC dated August 31, 2022 (Filed With SEC on November 9, 2022)
- Amended and Restated Promissory Note between ImmunityBio, Inc. and Nant Capital, LLC dated August 31, 2022 (Filed With SEC on November 9, 2022)
- Promissory Note between ImmunityBio, Inc. and Nant Capital, LLC dated August 31, 2022 (Filed With SEC on November 9, 2022)
- Promissory Note by and between the Company and Nant Capital, LLC dated as of December 17, 2021 (Filed With SEC on December 20, 2021)
- Promissory Note, dated February 22, 2021, issued by NantCell, Inc. (f/k/a ImmunityBio, Inc.) to Nant Capital, LLC (Filed With SEC on March 10, 2021)
- Promissory Note, dated September 30, 2020, issued by ImmunityBio, Inc. to Nant Capital, LLC (Filed With SEC on January 19, 2021)
- Amended and Restated Promissory Note, dated July 28, 2020, issued by ImmunityBio, Inc. to NantMobile, LLC (Filed With SEC on January 19, 2021)
- Amended and Restated Promissory Note, dated July 28, 2020, issued by ImmunityBio, Inc. to NantCancerStemCell, LLC (Filed With SEC on January 19, 2021)
- Amended and Restated Promissory Note, dated July 28, 2020, issued by ImmunityBio, Inc. to NantWorks, LLC (Filed With SEC on January 19, 2021)
- Amended and Restated Promissory Note, dated July 28, 2020, issued by ImmunityBio, Inc. to Nant Capital, LLC (Filed With SEC on January 19, 2021)